[DOI] [PMC free article] [PubMed] [Google Scholar] 94.Tsai C.-Y., Lu H.-C., Chou Y.-H., Liu P.-Y., Chen H.-Y., Huang M.-C., Lin C.-H., Tsai C.-N
Originally FDA-approved for type 2 diabetes, several now carry indications for weight management and cardiovascular risk reduction
In patients with T2D in a phase 2 clinical trial, retatrutide (0.5 to 12 mg) significantly reduced body weight and HbA1c levels compared to placebo and 1.5 mg dulaglutide
For most people, they last seconds to minutes and resolve on their own, but when they repeat or come with lightheadedness or chest pain, they require prompt evaluation
One in five, or 20% of Americans, said they'd taken the medication at some time
These specialists assess your entire metabolic profile, including thyroid function, insulin resistance, cortisol levels, and other hormonal factors that might influence weight management